Energy substrate utilization is altered in hypertrophied and failing hearts. Specifically, hypertrophied hearts show increases in basal glucose uptake and glycolysis, associated with decreases in fatty acid oxidation, suggesting a shift of substrate preference in these hearts. One key player for energy substrate switch in the heart is peroxisome proliferator activated receptor alpha (PPAR alpha), a nuclear receptor that regulates expressions of multiple genes controlling fatty acid metabolism. Down-regulation of PPAR alpha, widely observed in cardiac hypertrophy, allows shifting substrate preference from fatty acid to glucose; and was thought to be a necessary adaptation in hypertrophied hearts. Down-regulation of PPAR alpha alone, however, does not prevent the development of heart failure, and decreases in the protein or activity of enzymes encoded by PPAR alpha parallel the transition from compensated hypertrophy to failure. Thus, the functional significance of substrate switch remains incompletely understood. In the previous funding period, we generated transgenic mice with cardiac-specific overexpression of insulin-independent glucose transporter GLUT1 (TG). The TG hearts have successfully recapitulated the increases in glucose uptake and glycolysis observed in hypertrophied hearts but at a substantially higher level. Using this model, we have made the exciting observation that increasing glucose transport protects against the development of heart failure and improves the survival in mice with ascending aortic constriction. The goal of this application is to determine why chronic increases in glucose uptake prevent the development of heart failure and to test potential therapeutic approaches. Our central hypothesis is that the benefit of increasing glucose uptake in hypertrophied hearts derives from increases both in glycolysis and glucose oxidation: Increased glycolytic ATP production supports sarcoplasmic reticulum Ca2+-ATPase (SERCA) during chronic hemodynamic overload and increased glucose oxidation enhance the substrate shift initiated by the down-regulation of PPAR alpha and thereby achieving an adaptive energy metabolism in hypertrophied hearts.
Our specific aims are test the following hypotheses: 1) further enhancing glucose transport in hearts with down-regulation of PPAR alpha is necessary to establish an adaptive substrate oxidation profile for high workload. 2) increasing ATP generation via glycolysis improves SERCA function and maintains Ca 2. homeostasis in hypertrophied cardiac myocytes. 3) increasing glucose transport in failing hearts improves energy supply and contractile performance. 4) increasing glucose transport enhances the efficacy of SERCA2a overexpression in the treatment of heart failure. ? ?

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Cardiovascular and Renal Study Section (CVB)
Program Officer
Varghese, Jamie
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brigham and Women's Hospital
United States
Zip Code
Roe, Nathan D; Standage, Stephen W; Tian, Rong (2016) The Relationship Between KLF5 and PPAR? in the Heart: It's Complicated. Circ Res 118:193-5
Yu, Qiujun; Lee, Chi Fung; Wang, Wang et al. (2014) Elimination of NADPH oxidase activity promotes reductive stress and sensitizes the heart to ischemic injury. J Am Heart Assoc 3:e000555
Kolwicz Jr, Stephen C; Purohit, Suneet; Tian, Rong (2013) Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res 113:603-16
Marney, Luke C; Kolwicz Jr, Stephen C; Tian, Rong et al. (2013) Sample preparation methodology for mouse heart metabolomics using comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry. Talanta 108:123-30
Kolwicz Jr, Stephen C; Olson, David P; Marney, Luke C et al. (2012) Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy. Circ Res 111:728-38
Karamanlidis, Georgios; Bautista-Hernandez, Victor; Fynn-Thompson, Francis et al. (2011) Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease. Circ Heart Fail 4:707-13
Kolwicz Jr, Stephen C; Tian, Rong (2011) Glucose metabolism and cardiac hypertrophy. Cardiovasc Res 90:194-201
Kolwicz Jr, Stephen C; Tian, Rong (2010) Assessment of cardiac function and energetics in isolated mouse hearts using 31P NMR spectroscopy. J Vis Exp :
Karamanlidis, Georgios; Nascimben, Luigino; Couper, Gregory S et al. (2010) Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ Res 106:1541-8
Yan, Jie; Young, Martin E; Cui, Lei et al. (2009) Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation 119:2818-28

Showing the most recent 10 out of 11 publications